Medicina clinica (English ed.)最新文献

筛选
英文 中文
High flow arteriovenous fistula: a cause of reversible heart failure in hemodialysis 高流量动静脉瘘:血液透析中可逆性心力衰竭的一个原因
Medicina clinica (English ed.) Pub Date : 2024-10-25 DOI: 10.1016/j.medcle.2024.04.021
Elena Jiménez Mayor , Silvia González Sanchidrián , Miguel Ángel Silva Cerpa
{"title":"High flow arteriovenous fistula: a cause of reversible heart failure in hemodialysis","authors":"Elena Jiménez Mayor , Silvia González Sanchidrián , Miguel Ángel Silva Cerpa","doi":"10.1016/j.medcle.2024.04.021","DOIUrl":"10.1016/j.medcle.2024.04.021","url":null,"abstract":"","PeriodicalId":74154,"journal":{"name":"Medicina clinica (English ed.)","volume":"163 8","pages":"Pages 423-424"},"PeriodicalIF":0.0,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142531703","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Connective tissue amyloidosis in patients referred for orthopedic surgery. CONNECT-AMY study 骨科手术转诊患者中的结缔组织淀粉样变性。CONNECT-AMY 研究
Medicina clinica (English ed.) Pub Date : 2024-10-25 DOI: 10.1016/j.medcle.2024.10.001
Gonzalo Barge-Caballero , Alicia Freire-Ruaño , Alba González-Rodríguez , Juan M. Villa-Fernández , Jorge Pombo-Otero , María G. Crespo-Leiro
{"title":"Connective tissue amyloidosis in patients referred for orthopedic surgery. CONNECT-AMY study","authors":"Gonzalo Barge-Caballero ,&nbsp;Alicia Freire-Ruaño ,&nbsp;Alba González-Rodríguez ,&nbsp;Juan M. Villa-Fernández ,&nbsp;Jorge Pombo-Otero ,&nbsp;María G. Crespo-Leiro","doi":"10.1016/j.medcle.2024.10.001","DOIUrl":"10.1016/j.medcle.2024.10.001","url":null,"abstract":"<div><h3>Introduction and objective</h3><div>Clinical manifestations secondary to amyloid deposition in connective tissue may allow early detection of amyloidosis. We sought to identify the prevalence of connective tissue amyloidosis in patients undergoing orthopedic surgery and evaluate for cardiac involvement.</div></div><div><h3>Material and methods</h3><div>Descriptive cross-sectional study that included patients &gt;50 years referred for orthopedic surgery at our center. A sample of the affected connective tissue was taken during the intervention to evaluate the presence of amyloid material. Those with confirmed amyloidosis were further evaluated with complementary tests for cardiac involvement.</div></div><div><h3>Results</h3><div>Forty-eight patients were included. Mean age was 65.4 years and 41.7% were women. The most frequent surgery was supraspinatus tendon rupture (50%). Transthyretin amyloid deposits were detected in 2 patients (4.2%). The absence of variants in the protein gene established the diagnosis of ATTRwt in both cases. None of them presented cardiac involvement.</div></div><div><h3>Conclusions</h3><div>In this study, 4.2% of patients referred for orthopedic surgery presented transthyretin amyloidosis in the affected connective tissue.</div></div>","PeriodicalId":74154,"journal":{"name":"Medicina clinica (English ed.)","volume":"163 8","pages":"Pages e84-e88"},"PeriodicalIF":0.0,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142532117","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neuropsychiatric symptoms of patients two years after experiencing severe COVID-19: A mixed observational study 严重 COVID-19 患者两年后的神经精神症状:混合观察研究
Medicina clinica (English ed.) Pub Date : 2024-10-25 DOI: 10.1016/j.medcle.2024.05.009
José Miguel Meca-García , María Teresa Perní-Lasala , Tesifón Parrón-Carreño , David Lozano-Paniagua , Gracia Castro-Luna , Bruno José Nievas-Soriano
{"title":"Neuropsychiatric symptoms of patients two years after experiencing severe COVID-19: A mixed observational study","authors":"José Miguel Meca-García ,&nbsp;María Teresa Perní-Lasala ,&nbsp;Tesifón Parrón-Carreño ,&nbsp;David Lozano-Paniagua ,&nbsp;Gracia Castro-Luna ,&nbsp;Bruno José Nievas-Soriano","doi":"10.1016/j.medcle.2024.05.009","DOIUrl":"10.1016/j.medcle.2024.05.009","url":null,"abstract":"<div><h3>Background</h3><div>The impact of SARS-CoV-2 infection (COVID-19) on mental health has not been extensively studied in the medium and long term. This study assessed how clinical, biological, and social factors affect mental health in patients who recovered from severe COVID-19. The evaluation was done 90 days after hospital discharge and followed up at 12 and 24 months.</div></div><div><h3>Methods</h3><div>A retrospective-prospective cohort mixed observational study was conducted on patients over 18 years of age who required hospitalization in Internal Medicine or ICU for severe COVID-19 pneumonia during 2020 and 2021. Demographic information, clinical variables, and data for the scales were obtained from electronic medical records and telephone interviews. For comparisons of the different variables in each clinical variable (insomnia, depression, anxiety), the Student's <em>t</em>-test for independent samples has been used (normal distribution); otherwise, the Mann–Whitney test will be used. All tests and intervals will be performed with a confidence level of 95. Fisher's exact or Pearson's Chi-square test has been used as appropriate for qualitative variables.</div></div><div><h3>Results</h3><div>201 patients were recruited. 37.3% presented insomnia, 22.4% anxiety, and 21.4% depressive symptoms. A direct association was established between female sex and depressive symptoms. Psychotropic history, fatigue, and C-reactive protein levels (CRP) were correlated with depression. Anosmia and ageusia, CRP, cognitive symptoms, and dyspnea predicted insomnia. Sex, orotracheal intubation (OTI), pain, fatigue, mental health history, and academic level were independent predictors of anxiety. High percentages of depressive, anxiety, and insomnia symptoms were detected in the second month after discharge and persisted at 12 and 24 months. The fatigue variable maintained a significant relationship with depressive symptoms at 2, 12 and 24 months. A possible limitation could be recall bias in retrospective data collection.</div></div><div><h3>Conclusions</h3><div>This is a novel study to follow up on mental health for two years in patients with severe COVID-19. Clinical, biological, and psychosocial variables could be predictors of depressive symptoms, anxiety, and insomnia. The psychiatric symptoms persisted throughout the 2-year follow-up. These findings are critical for the follow-up of these patients and open the possibility of further studies in the medium and long term.</div></div>","PeriodicalId":74154,"journal":{"name":"Medicina clinica (English ed.)","volume":"163 8","pages":"Pages 383-390"},"PeriodicalIF":0.0,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142531691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Polycystic ovary syndrome with a Sertoli-Leydig cell tumor: A case report 多囊卵巢综合征合并 Sertoli-Leydig 细胞肿瘤:病例报告
Medicina clinica (English ed.) Pub Date : 2024-10-25 DOI: 10.1016/j.medcle.2024.04.025
Víctor Pérez de Arenaza Pozo, María Miguelez González, Luis Daniel Moya Orduñez
{"title":"Polycystic ovary syndrome with a Sertoli-Leydig cell tumor: A case report","authors":"Víctor Pérez de Arenaza Pozo,&nbsp;María Miguelez González,&nbsp;Luis Daniel Moya Orduñez","doi":"10.1016/j.medcle.2024.04.025","DOIUrl":"10.1016/j.medcle.2024.04.025","url":null,"abstract":"","PeriodicalId":74154,"journal":{"name":"Medicina clinica (English ed.)","volume":"163 8","pages":"Pages 429-430"},"PeriodicalIF":0.0,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142531696","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vanek's tumor: A differential diagnosis of colorectal cancer 瓦内克肿瘤大肠癌的鉴别诊断
Medicina clinica (English ed.) Pub Date : 2024-10-25 DOI: 10.1016/j.medcle.2024.01.046
Víctor Domínguez-Prieto, Miguel León-Arellano, Héctor Guadalajara, Damián García-Olmo
{"title":"Vanek's tumor: A differential diagnosis of colorectal cancer","authors":"Víctor Domínguez-Prieto,&nbsp;Miguel León-Arellano,&nbsp;Héctor Guadalajara,&nbsp;Damián García-Olmo","doi":"10.1016/j.medcle.2024.01.046","DOIUrl":"10.1016/j.medcle.2024.01.046","url":null,"abstract":"","PeriodicalId":74154,"journal":{"name":"Medicina clinica (English ed.)","volume":"163 8","pages":"Page e83"},"PeriodicalIF":0.0,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142531697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trends in authorship in Medicina Clínica: an 11-year analysis of author gender 临床医学》的作者趋势:对作者性别的 11 年分析
Medicina clinica (English ed.) Pub Date : 2024-10-25 DOI: 10.1016/j.medcle.2024.01.044
Xenia Artiga-Solana , Ernesto Muñoz-Mahamud , Andrés Combalia
{"title":"Trends in authorship in Medicina Clínica: an 11-year analysis of author gender","authors":"Xenia Artiga-Solana ,&nbsp;Ernesto Muñoz-Mahamud ,&nbsp;Andrés Combalia","doi":"10.1016/j.medcle.2024.01.044","DOIUrl":"10.1016/j.medcle.2024.01.044","url":null,"abstract":"","PeriodicalId":74154,"journal":{"name":"Medicina clinica (English ed.)","volume":"163 8","pages":"Pages 415-420"},"PeriodicalIF":0.0,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142531701","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perianal cutaneous tuberculosis: A case study 肛周皮肤结核病例研究
Medicina clinica (English ed.) Pub Date : 2024-10-25 DOI: 10.1016/j.medcle.2024.04.024
José Juan Parra García, Marta Segado Sánchez, Miguel Lova Navarro
{"title":"Perianal cutaneous tuberculosis: A case study","authors":"José Juan Parra García,&nbsp;Marta Segado Sánchez,&nbsp;Miguel Lova Navarro","doi":"10.1016/j.medcle.2024.04.024","DOIUrl":"10.1016/j.medcle.2024.04.024","url":null,"abstract":"","PeriodicalId":74154,"journal":{"name":"Medicina clinica (English ed.)","volume":"163 8","pages":"Pages 427-428"},"PeriodicalIF":0.0,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142531695","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
External validation of the FAscore scale to evaluate the risk of atrial fibrillation in patients with arterial hypertension 评估动脉高血压患者心房颤动风险的 FAscore 量表的外部验证
Medicina clinica (English ed.) Pub Date : 2024-10-25 DOI: 10.1016/j.medcle.2024.05.010
Luis Mújica-Jauregui , Vicente Bertomeu-González , Álvaro Carbonell-Soliva , Domingo Orozco-Beltrán , Vicente F. Gil-Guillén , Rauf Nouni-García , Adriana López-Pineda , Concepción Carratalá-Munuera , Jose A. Quesada
{"title":"External validation of the FAscore scale to evaluate the risk of atrial fibrillation in patients with arterial hypertension","authors":"Luis Mújica-Jauregui ,&nbsp;Vicente Bertomeu-González ,&nbsp;Álvaro Carbonell-Soliva ,&nbsp;Domingo Orozco-Beltrán ,&nbsp;Vicente F. Gil-Guillén ,&nbsp;Rauf Nouni-García ,&nbsp;Adriana López-Pineda ,&nbsp;Concepción Carratalá-Munuera ,&nbsp;Jose A. Quesada","doi":"10.1016/j.medcle.2024.05.010","DOIUrl":"10.1016/j.medcle.2024.05.010","url":null,"abstract":"<div><h3>Background and aim</h3><div>To use a risk scale or predictive model outside the population of origin, it is necessary to evaluate the predictive indicators through external validation. The aim was to validate the FAscore, originally constructed in hypertensive patients in primary care in the Valencian Region, in an external cohort with hypertension in primary care in the Basque Country.</div></div><div><h3>Methods</h3><div>A retrospective cohort study was designed to perform an external validation of the FAscore app in patients affiliated with 26 health centers in the municipality of Bilbao. The area under the ROC curve and predictive indicators were calculated with their 95% confidence intervals.</div></div><div><h3>Results</h3><div>Thirty-six thousand eight hundred nine patients were included: 53.6% (<em>n</em> <!-->=<!--> <!-->19,719) were women, the mean age was 75.1 years, 41.8% (<em>n</em> <!-->=<!--> <!-->15,381). Over the four-year follow-up period, 1420 patients were diagnosed with AF (cumulative incidence 3.9%). The median risk estimated by FAscore was 4.5%, and the 5th, 25th, 75th, and 95th percentiles were 1.0%, 2.5%, 6.1%, and 14.8%, respectively. The ROC curve for the risk estimated by FAscore and the cases of atrial fibrillation observed was AUC 0.715 (95% CI 0.703–0.727). The 5% risk cutoff provides a sensitivity of 70.8%, specificity of 61.0%, positive predictive value of 6.8%, negative predictive value of 98.1%, and positive and negative likelihood ratios of 1.82 and 0.48, respectively.</div></div><div><h3>Conclusion</h3><div>This study reports on the external validation of the atrial fibrillation risk scale in hypertensive patients, which shows an acceptable predictive capacity. The best-performing risk cutoff, providing good predictive indicators, can be set at 5%.</div></div>","PeriodicalId":74154,"journal":{"name":"Medicina clinica (English ed.)","volume":"163 8","pages":"Pages 397-403"},"PeriodicalIF":0.0,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142531698","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness and safety of alirocumab and evolocumab for hypercholesterolemia in a population with high cardiovascular risk 阿利珠单抗和埃沃洛单抗治疗高心血管风险人群高胆固醇血症的有效性和安全性
Medicina clinica (English ed.) Pub Date : 2024-10-09 DOI: 10.1016/j.medcle.2024.05.007
Montserrat Bosch , Immaculada Danés , Elena Ballarín , Patricia Marrero , Guillem Vancells , Ángel Ortiz-Zúñiga , Maria Urquizu-Padilla , Nuria Rial-Lorenzo , Jordi Lozano-Torres , David Rodríguez-Luna , Francesca Filippi-Arriaga , Antònia Agustí
{"title":"Effectiveness and safety of alirocumab and evolocumab for hypercholesterolemia in a population with high cardiovascular risk","authors":"Montserrat Bosch ,&nbsp;Immaculada Danés ,&nbsp;Elena Ballarín ,&nbsp;Patricia Marrero ,&nbsp;Guillem Vancells ,&nbsp;Ángel Ortiz-Zúñiga ,&nbsp;Maria Urquizu-Padilla ,&nbsp;Nuria Rial-Lorenzo ,&nbsp;Jordi Lozano-Torres ,&nbsp;David Rodríguez-Luna ,&nbsp;Francesca Filippi-Arriaga ,&nbsp;Antònia Agustí","doi":"10.1016/j.medcle.2024.05.007","DOIUrl":"10.1016/j.medcle.2024.05.007","url":null,"abstract":"<div><h3>Background and aims</h3><div>The criteria for the use of proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) more restrictive than those approved were established in Catalonia by the Health System (CatSalut) to improve their efficiency, with different LDL-C values from which to start treatment according to risk factors. The aim of the study is to analyse adherence to these criteria and results.</div></div><div><h3>Methods</h3><div>A retrospective study of patients treated with PCSK9i at Vall d’Hebron University Hospital between 2016 and 2021 was performed using data from the Registry of Patients and Treatments and medical records. The degree of agreement with the CatSalut criteria, LDL-C-responders (decrease ≥30%), cardiovascular events and discontinuations were analysed.</div></div><div><h3>Results</h3><div>A total of 193 patients treated with PCSK9i were followed for a median of 27 months (IQR 23). The median age was 61 (IQR 15); 62.7% were men. Seventy percent of the patients had non-familial hypercholesterolemia. Treatment was for secondary prevention of cardiovascular disease in 82.4% of cases. The median LDL-C decreased from 139 (IQR 52) to 59 (IQR 45) mg/dL. The percentage of LDL-C reduction was 61.0% (IQR 30). In 72.5% of patients, all CatSalut criteria for starting treatment were met. The rate of responders was 85.4%. During follow-up, 19 patients (9.8%) had a cardiovascular event, and 15 (7.7%) discontinued treatment, in two cases due to toxicity.</div></div><div><h3>Conclusion</h3><div>PCSK9i were used according to CatSalut criteria in three out of four cases. In this high-risk population, incidence of cardiovascular events was similar to that in clinical trials.</div></div>","PeriodicalId":74154,"journal":{"name":"Medicina clinica (English ed.)","volume":"163 7","pages":"Pages 317-322"},"PeriodicalIF":0.0,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142417987","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Health administration key role in curbing antimicrobial resistance 卫生行政部门在遏制抗菌药耐药性方面发挥关键作用
Medicina clinica (English ed.) Pub Date : 2024-10-09 DOI: 10.1016/j.medcle.2024.04.016
Carl Llor
{"title":"Health administration key role in curbing antimicrobial resistance","authors":"Carl Llor","doi":"10.1016/j.medcle.2024.04.016","DOIUrl":"10.1016/j.medcle.2024.04.016","url":null,"abstract":"","PeriodicalId":74154,"journal":{"name":"Medicina clinica (English ed.)","volume":"163 7","pages":"Pages 372-373"},"PeriodicalIF":0.0,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142418039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信